David Krempa
Corporate Officer/Principal bei ETON PHARMACEUTICALS, INC.
Vermögen: 64 899 $ am 30.04.2024
Profil
David C.
Krempa is currently the Chief Business Officer at Eton Pharmaceuticals, Inc. He previously worked at Akorn, Inc. in Business Development-Sagent Pharmaceuticals.
Additionally, he worked as an Equity Analyst at Morningstar, Inc. (Research) from 2014 to 2015.
Mr. Krempa completed his undergraduate degree at DePaul University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
12.04.2024 | 20 801 ( 0,08% ) | 64 899 $ | 30.04.2024 |
Aktive Positionen von David Krempa
Unternehmen | Position | Beginn |
---|---|---|
ETON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2023 |
Ehemalige bekannte Positionen von David Krempa
Unternehmen | Position | Ende |
---|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Analyst-Equity | 01.03.2015 |
AKORN, INC. | Corporate Officer/Principal | - |
Ausbildung von David Krempa
DePaul University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ETON PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |